
201 - 500 employees
Founded 2017
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $125M Post-IPO Equity - Stoke Therapeutics on 2024-03
Biotechnology • Pharmaceuticals • Healthcare
Stoke Therapeutics is a biotechnology company developing RNA-based therapeutics that increase protein production from a patient’s own genes to treat rare genetic diseases. Its TANGO (Targeted Augmentation of Nuclear Gene Output) platform uses antisense oligonucleotides to upregulate gene expression in haploinsufficiency disorders. Lead programs include STK‑001, an antisense therapy in development for Dravet syndrome (SCN1A haploinsufficiency), and other programs focused on genetic neurology and rare disease indications.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2017
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $125M Post-IPO Equity - Stoke Therapeutics on 2024-03
Biotechnology • Pharmaceuticals • Healthcare
Stoke Therapeutics is a biotechnology company developing RNA-based therapeutics that increase protein production from a patient’s own genes to treat rare genetic diseases. Its TANGO (Targeted Augmentation of Nuclear Gene Output) platform uses antisense oligonucleotides to upregulate gene expression in haploinsufficiency disorders. Lead programs include STK‑001, an antisense therapy in development for Dravet syndrome (SCN1A haploinsufficiency), and other programs focused on genetic neurology and rare disease indications.
• Serve as the primary relationship owner for all accounts in the region • Lead and execute Stoke’s payer access strategy from the ground up • Engage targeted accounts and policy decision-makers to advance coverage timelines • Establish Stoke’s credibility and share clinical data with medical benefit policy decision-makers • Develop and execute pre-launch and launch-phase access strategies • Serve as strategic leader for key accounts in the region • Develop account-specific action plans to shorten the timeline from FDA approval to positive coverage determination • Build payer relationships before NDA submission • Develop multi-year access plans anticipating commercial cycles and competitive coverage shifts • Educate payers on clinical evidence, FDA labeling, treatment guidelines, and health-economic data • Monitor medical policy language and partner with Medical Affairs, HEOR, and Advocacy • Engage payer Medical Directors to obtain guidance letters or billing instructions pending permanent J code assignment • Influence policy decision-makers to achieve desired coverage outcomes • Serve as subject-matter expert on buy-and-bill reimbursement for miscellaneous J codes • Educate payer medical policy teams on claims submission, billing units, and NDC-to-J code crosswalks • Drive alignment across commercial and field medical teams and cross-functional departments • Coordinate field reimbursement and patient services to support approval success and timely patient access • Engage the Dravet syndrome patient and caregiver community • Conduct payer engagements in compliance with company SOPs, OIG guidelines, PhRMA Code, and applicable regulations • Navigate access challenges for a first-in-class disease-modifying ASO therapy
• Bachelor’s degree required; advanced degree (MBA, MPH, PharmD) preferred • 15+ years in pharma/biotech • Minimum 10 years in payer account management with lead responsibility for one of the three large PBM and National accounts • Proven track record of achieving positive coverage outcomes for orphan designation or rare disease products on the medical benefit • Pre-launch payer strategy experience • Hands-on experience navigating a miscellaneous J code (J3490/J3590) environment, including transition to a permanent product-specific code • Strong command of managed care economics, formulary management, utilization management, and coverage policy development processes at national payers • Rare pediatric or neurological disease product launch experience; CNS or epilepsy payer experience a significant differentiator • Familiarity with disease-modifying therapy and gene testing reimbursement pathways as established according to payer policy • Experience at a startup or early commercial-stage biotech building its commercial infrastructure for the first time • Exceptional ability to influence across functions without direct authority • Passion for patient access and rare-disease impact • Proximity to a major US airport preferred • Approximately 50% travel
• Annual bonus • Equity participation • Medical insurance • Dental insurance • Vision insurance • Life insurance • Long- and short-term disability insurance • Paid parental leave • 401K plan with company match • Unlimited vacation time • Tuition assistance • Employee Stock Purchase Program (ESPP) • Flexible work arrangements • Employee-led Diversity, Inclusion, and Belonging (DIB) Committee
Apply Now🔥 29 minutes ago
Higher education practice leader driving Panopto’s video technology growth and institutional adoption. Advising campus executives and shaping go-to-market strategy for academic video technology.
🇺🇸 United States – Remote
💵 $160k - $200k / year
💰 Private Equity Round on 2021-04
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🔥 29 minutes ago
Director leading enterprise learning practice, executive advisory, and pipeline growth for Panopto’s video knowledge platform. Partnering with sales and product teams across Fortune 500 accounts.
🇺🇸 United States – Remote
💵 $160k - $200k / year
💰 Private Equity Round on 2021-04
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🔥 49 minutes ago
Senior nonclinical safety leader guiding toxicologic pathology and regulatory strategy at Gilead, a biopharmaceutical company developing therapies for major diseases. Leading R&D teams, studies, and submissions.
🇺🇸 United States – Remote
💵 $237.6k - $307.4k / year
💰 $3.5M Post-IPO Debt - Gilead Sciences on 2024-11
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🔥 1 hour ago
Sr Director leading nonclinical safety and toxicologic pathology for Gilead, a biopharmaceutical company developing therapies for major diseases. Guiding regulatory, pathology, and drug development programs.
🔥 2 hours ago
Senior Director of Talent booking instructors and leading talent acquisition and relations for MasterClass’s streaming education platform. Negotiating high-profile talent deals across classes, podcasts, events, and certificate programs.